Norwest Venture Partners, the 55-year-old, Palo Alto, Calif.-based venture firm, has closed its third consecutive $1.2 billion fund. The group, which employs 20 investors altogether, raised the same a
In August 2011, Intersect won approval from the FDA for <a target="_blank" href="http://www.intersectent.com/advantage-propel_steroid_releasing_implant.html">Propel</a>, which, simply put, is a stent